257 results on '"Albertelli, Manuela"'
Search Results
2. Current perspectives in obesity management: unraveling the impact of different therapy approach in real life obesity care
3. An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
4. Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-up
5. The diagnostic and prognostic role of combined [18F]FDG and [68Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience
6. Inibitori dei checkpoint immunitari e patologia tiroidea
7. Ianus Bifrons: The Two Faces of Metformin
8. "Present and future of immunotherapy in Neuroendocrine Tumors"
9. GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients
10. L’ipovitaminosi D nell’anziano: indicazioni al trattamento
11. Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxide
12. Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients
13. Neuroendocrine Tumours: Diagnosis, Therapy and Follow-up
14. The Molecular Biology of NET: Current Status and Evaluation of Biomarkers for Prediction and Prognosis
15. Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays
16. Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly
17. Impact of Vitamin D Deficiency on Tumor Aggressiveness in Neuroendocrine Neoplasms
18. Gender related differences in patients with carcinoid syndrome: new insights from a multicenter retrospective study
19. The diagnostic and prognostic role of combined [18F]FDG and [68Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience
20. KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?
21. Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review
22. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors
23. Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives
24. Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study
25. One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients
26. The treatment of hyperinsulinemic hypoglycaemia in adults: an update
27. Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients
28. Ectopic Cushing and Other Paraneoplastic Syndromes in Thoracic Neuroendocrine Tumors
29. Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies
30. The Molecular Biology of NET: Current Status and Evaluation of Biomarkers for Prediction and Prognosis
31. The diagnostic and prognostic role of combined [18F]FDG and [68Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience.
32. Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible?
33. Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study
34. Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose
35. Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone replacement therapy in adults with growth hormone deficiency
36. Prognostic Effect of Lymph Node Metastases and Mesenteric Deposits in Neuroendocrine Tumors of the Small Bowel
37. 2-[18F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study
38. Cortistatins and Dopastatins
39. Insights into Mechanisms of Tumorigenesis in Neuroendocrine Neoplasms
40. Diabetes Secondary to Neuroendocrine Gastroenteropancreatic Tumors
41. Prognostic features of gastro‐entero‐pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties
42. GH Replacement in the Elderly: Is It Worth It?
43. Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes
44. Sodium Intake and Target Organ Damage in Hypertension-An Update about the Role of a Real Villain
45. Erratum to: KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?
46. Ultrasound guided robotic enucleation of functioning pancreatic head insulinoma.
47. The role of cardiovascular assessment in low risk thyroid neoplasm patients: results from a tertiary care center experience
48. Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation
49. Somatostatin receptor pathophysiology in the neuroendocrine system
50. Efficacy of a Novel Second-Generation Somatostatin-Dopamine Chimera (TBR-065) in Human Medullary Thyroid Cancer: A Preclinical Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.